About | Home | Search
Pubget
Find your PDFs fast.
Welcome to the Pubget Medical Subject Headings (MESH) browser. Click on a topic or subtopic below to explore related papers. In the gold box is the most recent paper about the current MESH term, and below are 20 related papers.
Enzyme Inhibitors (16):
  • Folic Acid Antagonists
  • Nucleic Acid Synthesis Inhibitors
  • Cyclooxygenase Inhibitors
  • Protein Synthesis Inhibitors
  • Phosphodiesterase Inhibitors
  • Monoamine Oxidase Inhibitors
  • Lipoxygenase Inhibitors
  • Protein Kinase Inhibitors
  • Integrase Inhibitors
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Proton Pump Inhibitors
  • Cholinesterase Inhibitors
  • Carbonic Anhydrase Inhibitors
  • Uncoupling Agents
  • Protease Inhibitors
  • Aromatase Inhibitors
Home > Chemical Actions and Uses > Pharmacologic Actions > Molecular Mechanisms of Pharmacological Action > Enzyme Inhibitors

Recent article

Enzyme Inhibitors

International Journal of Molecular Medicine (28)6 2011
Inhibitory effects of vitamin K₃ derivatives on DNA polymerase and inflammatory activity.
Aoganghua Aoganghua, Shin Nishiumi, Kazuki Kobayashi, Masayuki Nishida, Kouji Kuramochi, Kazunori Tsubaki, Midori Hirai, Shinwa Tanaka, Takeshi Azuma, Hiromi Yoshida, Yoshiyuki Mizushina and Masaru Yoshida
Abstract
We reported that vitamin K₃ (menadione, 2-methyl-1,4-naphthoquinone) (compound 2) inhibits the activity of human mitochondrial DNA polymerase γ (pol γ). In this study, we investigated the inhibitory effects (IEs) of vitamin K3 and its derivatives, such as 1,4-naphthoquinone (compound 1) and 1,2-... | PMID: 21837358

Large_pdficon_selected PDF is available here.
< More recent Older article >
New England Journal of Medicine (365)14 2011
Randomized trial of oral teriflunomide for relapsing multiple sclerosis.
Paul O'Connor, Jerry S Wolinsky, Christian Confavreux, Giancarlo Comi, Ludwig Kappos, Tomas P Olsson, Hadj Benzerdjeb, Philippe Truffinet, Lin Wang, Aaron Miller, Mark S Freedman and TEMSO Trial Group
Abstract
We concluded a randomized trial involving 1088 patients with multiple sclerosis, 18 to 55 years of age, with a score of 0 to 5.5 on the Expanded Disability Status Scale and at least one relapse in the previous year or at least two relapses in the previous 2 years. Patients were randomly assigned (in... | PMID: 21991951

Large_pdficon_selected PDF is available here.
New England Journal of Medicine (365)12 2011
Resolving the scar of pulmonary fibrosis.
Gregory P Downey
Abstract
PMID: 21992127

Large_pdficon_selected PDF is available here.
New England Journal of Medicine (365)12 2011
Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis.
Luca Richeldi, Ulrich Costabel, Moises Selman, Dong Soon Kim, David M Hansell, Andrew G Nicholson, Kevin K Brown, Kevin R Flaherty, Paul W Noble, Ganesh Raghu, Michèle Brun, Abhya Gupta, Nolwenn Juhel, Matthias Klüglich and Roland M du Bois
Abstract
A total of 432 patients underwent randomization to receive one of four doses of BIBF 1120 (50 mg once a day, 50 mg twice a day, 100 mg twice a day, or 150 mg twice a day) or placebo. In the group receiving 150 mg of BIBF 1120 twice a day, FVC declined by 0.06 liters per year, as compared with 0.19 l... | PMID: 21992121

Large_pdficon_selected PDF is available here.
Circulation (124)10 2011
Donor simvastatin treatment abolishes rat cardiac allograft ischemia/reperfusion injury and chronic rejection through microvascular protection.
Raimo Tuuminen, Simo Syrjälä, Rainer Krebs, Mikko A I Keränen, Katri Koli, Usama Abo-Ramadan, Pertti J Neuvonen, Jussi M Tikkanen, Antti I Nykänen and Karl B Lemström
Abstract
We report that rat cardiac allograft ischemia/reperfusion injury resulted in profound microvascular dysfunction that was prevented by donor treatment with peroral single-dose simvastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase and Rho GTPase inhibitor, 2 hours before graft procurement. Du... | PMID: 21844074

Large_pdficon_selected PDF is available here.
Biochemical and Biophysical Research Communications (412)2 2011
PARP1 inhibitors attenuate AKT phosphorylation via the upregulation of PHLPP1.
Shuai Wang, Huibo Wang, Ben C Davis, Jiyong Liang, Rutao Cui, Sai-Juan Chen and Zhi-Xiang Xu
Abstract
We show that two PARP1 inhibitors, PJ-34 and 3-AB, attenuate AKT phosphorylation at serine 473 (S473) independent of DNA repair impairment. These inhibitors decrease the AKT-associated phosphorylation of FOXO3A, enhance the nuclear retention of FOXO3A, and activate its transcriptional activity. We f... | PMID: 21821012

Large_pdficon_selected PDF is available here.
Journal of Chemical Information and Modeling (51)8 2011
A data mining method to facilitate SAR transfer.
Anne Mai Wassermann and Jürgen Bajorath
Abstract
We present a data mining approach that enables the identification of alternative analog series with different core structures, corresponding substitution patterns, and comparable potency progression. Scaffolds can be exchanged between these series and new analogs suggested that incorporate preferred... | PMID: 21774471

Large_pdficon_selected PDF is available here.
Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova / Rossiiskaia akademiia nauk (97)8 2011
[Contribution of nitric oxide in the mechanisms of flow-dependent vasodilation in normo- and hypertensive rats].
D L DL Sonin, M M MM Galagudza, A V AV Syrenskiĭ, E I EI Egorova, M K MK Nekrasova and V A VA Tsyrlin
Abstract
The aim of this study was to evaluate the role of nitric oxide (NO) in the mechanisms of arterial distensibility and intravascular pressure stability in normotensive and spontaneously hypertensive rats. The experiments were performed on the anesthetized male Wistar, Wistar-Kyoto (WKY... | PMID: 21961305

Large_pdficon_selected PDF is available here.
Pharmazie (66)7 2011
Tanshinone IIA prevents cardiac remodeling through attenuating NAD (P)H oxidase-derived reactive oxygen species production in hypertensive rats.
Ping Wang, Xiaoqian Wu, Yingxia Bao, Jian Fang, Sigui Zhou, Jie Gao, Rongbiao Pi, Yong-Gao Mou and Peiqing Liu
Abstract
We investigated the effects of Tan IIA on cardiac hypertrophy and fibrosis in two-kidney, two-clip (2K2C) hypertensive rats and by which, if any, mechanisms. Administration of 2K2C hypertensive rats with Tan IIA attenuated cardiac dysfunction and fibrosis. However Tan IIA treatment had no effects on... | PMID: 21812327

Large_pdficon_selected PDF is available here.
Biochimica et Biophysica Acta (1807)11 2011
The cytochrome bd respiratory oxygen reductases.
Vitaliy B VB Borisov, Robert B RB Gennis, James J Hemp and Michael I MI Verkhovsky
Abstract
Cytochrome bd is a respiratory quinol:O(2) oxidoreductase found in many prokaryotes, including a number of pathogens. The main bioenergetic function of the enzyme is the production of a proton motive force by the vectorial charge transfer of protons. The sequences of cytochromes bd are not homologous... | PMID: 21756872

Large_pdficon_selected PDF is available here.
Seminars in Oncology (38) 2011
Novel Agents and Future Directions for Refractory Breast Cancer
Harold J Burstein
Abstract
Tumor resistance remains a major clinical challenge. Numerous pathways are under investigation to determine how best to target therapies to specific mutations in tumor biology and circumvent resistance. Agents in development include inhibitors of the poly(adenosine diphosphate [ADP]-... | PMID: 21600381

Large_pdficon_selected PDF is available here.
Molecular Nutrition & Food Research (55)6 2011
Mechanistic issues concerning cancer prevention by tea catechins.
Chung S Yang and Hong Wang
Abstract
The cancer preventive activities of tea (Camellia sinensis, Theaceae) have been demonstrated in animal models for cancers at different organ sites and suggested by some epidemiological studies. Many mechanisms for cancer prevention have been proposed based on studies in cell lines, w... | PMID: 21538856

Large_pdficon_selected PDF is available here.
International Immunopharmacology (11)6 2011
Costunolide stimulates the function of osteoblastic MC3T3-E1 cells.
Young Soon Lee and Eun Mi Choi
Abstract
The effect of costunolide on the function of osteoblastic MC3T3-E1 cells was studied. Costunolide significantly increased the growth of MC3T3-E1 cells and caused a significant elevation of alkaline phosphatase (ALP) activity, collagen content, and mineralization in the cells (P<0.05)... | PMID: 21296696

Large_pdficon_selected PDF is available here.
Revue medicale suisse (7)296 2011
[Melanoma: a new therapeutic era].
G G Berthod, K K Homicsko, H H Bouchaab, M M Matter, J-P JP Cerottini, D D Guggisberg, D D Speiser, S S Leyvraz and O O Michielin
Abstract
We will cover the results obtained with targeted therapies such as "tyrosin kinase inhibitors" (TKI), as well as those obtained with a monoclonal antibody directed against the CTLA-4 receptor of lymphocytes.... | PMID: 21721201

Large_pdficon_selected PDF is available here.
Revue medicale suisse (7)296 2011
[PARP inhibitors: new therapeutic agents in breast and ovarian cancer].
L L Mercier-Vogel, A A Bodmer and M M Castiglione
Abstract
PARP inhibitors are novel drugs under development in oncology, particularly against breast and ovarian cancer. They act on the DNA repair mechanisms in synergy with the loss of BRCA function of the tumor cells, thereby inducing a genetic instability that leads to cell death. The clin... | PMID: 21721203

Large_pdficon_selected PDF is available here.
Cancer Cell (19)5 2011
Mechanistic rationale for inhibition of poly(ADP-ribose) polymerase in ETS gene fusion-positive prostate cancer.
J Chad Brenner, Bushra Ateeq, Yong Li, Anastasia K Yocum, Qi Cao, Irfan A Asangani, Sonam Patel, Xiaoju Wang, Hallie Liang, Jindan Yu, Nallasivam Palanisamy, Javed Siddiqui, Wei Yan, Xuhong Cao, Rohit Mehra, Aaron Sabolch, Venkatesha Basrur, Robert J Lonigro, Jun Yang, Scott A Tomlins, Christopher A Maher, Kojo S J Elenitoba-Johnson, Maha Hussain, Nora M Navone, Kenneth J Pienta, Sooryanarayana Varambally, Felix Y Feng and Arul M Chinnaiyan
Abstract
We investigate the mechanisms by which ETS fusions mediate their effects, and find that the product of the predominant ETS gene fusion, TMPRSS2:ERG, interacts in a DNA-independent manner with the enzyme poly (ADP-ribose) polymerase 1 (PARP1) and the catalytic subunit of DNA protein kinase (DNA-PKcs)... | PMID: 21575865

Large_pdficon_selected PDF is available here.
Xenobiotica (41)5 2011
Case report of extensive metabolism by aldehyde oxidase in humans: Pharmacokinetics and metabolite profile of FK3453 in rats, dogs, and humans
Takafumi Akabane, Kohichiro Tanaka, Megumi Irie, Shigeyuki Terashita and Toshio Teramura
Abstract
We focus on two sphingolipid signaling molecules, sphingosine-1-phosphate (S1P) and ceramide, as they are involved in cell fate decisions (survival vs. apoptosis) and in a wide range of pathophysiological processes. For S1P, we will discuss sphingosine kinases and S1P lyase as the enzymes which are... | PMID: 18751924

Large_pdficon_selected PDF is available here.
Xenobiotica (41)5 2011
Case report of extensive metabolism by aldehyde oxidase in humans: Pharmacokinetics and metabolite profile of FK3453 in rats, dogs, and humans
Takafumi Akabane, Kohichiro Tanaka, Megumi Irie, Shigeyuki Terashita and Toshio Teramura
Abstract
We recently showed that isolated replication complexes are able to synthesize two species of nascent viral RNA, one double stranded and the other single stranded. NS5B nucleoside inhibitors block synthesis of both species, whereas nonnucleoside inhibitors inhibit mostly single- tranded RNA synthesis... | PMID: 19009261

Large_pdficon_selected PDF is available here.
Medicinal Chemistry (7)3 2011
Exploring QSAR, pharmacophore mapping and docking studies and virtual library generation for cycloguanil derivatives as PfDHFR-TS inhibitors.
Probir Kumar Ojha and Kunal Roy
Abstract
We have performed QSAR, pharmacophore mapping and molecular docking studies of cycloguanil derivatives as Plasmodium falciparum dihydrofolate reductase thymidylate synthase (PfDHFR-TS) inhibitors to explore essential features required for the antimalarial activity and important interaction patterns... | PMID: 21486210

Large_pdficon_selected PDF is available here.
Journal of Immunotherapy (34)4 2011
Modulation of the poliovirus receptor expression in malignant lymphocytes by epigenetic alterations.
Wei Wang, Li Gao, Xinrong Wang, Huiyuan Kang, Yonghui Li, Lili Wang and Li Yu
Abstract
We have studied the mechanism of this defective expression of PVR. We demonstrated that the characterization of NK-insensitive cell lines was of low expression of PVR in both mRNA and surface levels, and that PVR of RAJI cells able to resist NK cells has hypermethylated promoter-associated CpG islan... | PMID: 21499126

Large_pdficon_selected PDF is available here.
Nature Immunology (12)5 2011
Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling.
Haitao Wen, Denis Gris, Yu Lei, Sushmita Jha, Lu Zhang, Max Tze-Han Huang, Willie June Brickey and Jenny P-Y Ting
Abstract
We show that the saturated fatty acid palmitate, but not unsaturated oleate, induces the activation of the NLRP3-ASC inflammasome, causing caspase-1, IL-1β and IL-18 production. This pathway involves mitochondrial reactive oxygen species and the AMP-activated protein kinase and unc-51-like kinase-1... | PMID: 21478880

Large_pdficon_selected PDF is available here.
Analytical and Bioanalytical Chemistry (400)5 2011
Development of an online SPE-LC-MS-based assay using endogenous substrate for investigation of soluble epoxide hydrolase (sEH) inhibitors.
Nils Helge Schebb, Marion Huby, Christophe Morisseau, Sung Hee Hwang and Bruce D Hammock
Abstract
We developed a new method utilizing an epoxide of arachidonic acid (14(15)-EpETrE) as substrate. Incubation samples were directly injected without purification into an online solid phase extraction (SPE) liquid chromatography electrospray ionization tandem mass spectrometry (LC-ESI-MS-MS) setup allo... | PMID: 21479549

Large_pdficon_selected PDF is available here.
Neuron (70)2 2011
mGluR5 and NMDA receptors drive the experience- and activity-dependent NMDA receptor NR2B to NR2A subunit switch.
Jose A Matta, Michael C Ashby, Antonio Sanz-Clemente, Katherine W Roche and John T R Isaac
Abstract
We show in hippocampal CA1 pyramidal neurons that the NR2B to NR2A switch driven acutely by activity requires activation of NMDARs and mGluR5, involves PLC, Ca(2+) release from IP(3)R-dependent stores, and PKC activity. In mGluR5 knockout mice the developmental NR2B-NR2A switch in CA1 is deficient.... | PMID: 21521618

Large_pdficon_selected PDF is available here.
Circulation (123)14 2011
Letter by Madias regarding article, "Relationship between nonsustained ventricular tachycardia after non-ST-elevation acute coronary syndrome and sudden cardiac death: observations from the Metabolic Efficiency with Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndrome-Thrombolysis in Myocardial Infarction 36 (MERLIN-TIMI 36) randomized controlled trial".
John E Madias
Abstract
PMID: 21482970

Large_pdficon_selected PDF is available here.
Circulation (123)14 2011
Letter by Ayalloore and LeLorier regarding article, "Relationship between nonsustained ventricular tachycardia after non-ST-elevation acute coronary syndrome and sudden cardiac death: observations from the Metabolic Efficiency with Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndrome-Thrombolysis in Myocardial Infarction 36 (MERLIN-TIMI 36) randomized controlled trial".
Siby G Ayalloore and Paul LeLorier
Abstract
PMID: 21482971

Large_pdficon_selected PDF is available here.
Pharmazie (66)4 2011
The cardiovascular inhibition functions of hydrogen sulfide within the nucleus tractus solitarii are mediated by the activation of KATP channels and glutamate receptors mechanisms.
Wei Qiao, Lei Yang, Xiao-Yun Li, Nong Cao, Wei-Zhong Wang, Chen Chai and Yan Lu
Abstract
Hydrogen sulfide (H2S), the colorless gas with the smell of rotten eggs, has been regarded as a novel gaseous signaling molecule. Although H2S has been proved been involved into the cardiovascular functions, the cardiovascular functions of H2S within the nucleus tractus solitarii (NT... | PMID: 21612157

Large_pdficon_selected PDF is available here.
Journal Of Tissue Engineering And Regenerative Medicine (5)4 2011
Site-specific tissue inhibitor of metalloproteinase-1 governs the matrix metalloproteinases-dependent degradation of crosslinked collagen scaffolds and is correlated with interleukin-10.
Q Ye, M J van Amerongen, J A Sandham, R A Bank, M J A van Luyn and M C Harmsen
Abstract
We have previously shown that the foreign body reaction (FBR) against crosslinked collagen type I (Col-I) differs between subcutaneous and epicardial implantation sites; Col-I was quickly degraded epicardially, whereas degradation was attenuated subcutaneously. The current study set out to dissect t... | PMID: 20661871

Large_pdficon_selected PDF is available here.
Future Medicinal Chemistry (3)5 2011
Small-molecule inhibitors of the PI3K signaling network.
Colleen R McNamara and Alexei Degterev
Abstract
We will summarize the PI3K signaling network and discuss current strategies for pathway inhibition. We will also explore the importance and emerging relevance of Akt-independent PI3K signaling pathways and discuss attempts being made to harness these pathways by inhibiting the binding of a product o... | PMID: 21526896

Large_pdficon_selected PDF is available here.
Future Medicinal Chemistry (3)5 2011
Small-molecule inhibitors of the PI3K signaling network.
Colleen R McNamara and Alexei Degterev
Abstract
We will summarize the PI3K signaling network and discuss current strategies for pathway inhibition. We will also explore the importance and emerging relevance of Akt-independent PI3K signaling pathways and discuss attempts being made to harness these pathways by inhibiting the binding of a product o... | PMID: 21526896

Large_pdficon_selected PDF is available here.
Pigment Cell & Melanoma Research (24)2 2011
A proliferative melanoma cell phenotype is responsive to RAF/MEK inhibition independent of BRAF mutation status.
Marie C Zipser, Ossia M Eichhoff, Daniel S Widmer, Natalie C Schlegel, Nicola L Schoenewolf, Darrin Stuart, Weihua Liu, Humphrey Gardner, Paul D Smith, Paolo Nuciforo, Reinhard Dummer and Keith S Hoek
Abstract
We investigated the effects of two different inhibitors of MAPK signaling in proliferative and invasive melanoma cell cultures with various mutations in the MAPK pathway. Proliferative melanoma cells were more susceptible to pathway inhibition than invasive phenotype cells, irrespective of BRAF muta... | PMID: 21176117

Large_pdficon_selected PDF is available here.
Journal of Molecular Modeling (17)4 2011
Relationship between mutation of serine residue at 315th position in M. tuberculosis catalase-peroxidase enzyme and Isoniazid susceptibility: an in silico analysis.
Rituraj Purohit, Vidya Rajendran and Rao Sethumadhavan
Abstract
We have conducted studies on the drug resistance through docking and binding analysis supported by time-scale (∼ 1000 ps) and unrestrained all-atom molecular dynamics simulations of wild and mutant MtBKatG. The study showed conformational changes of binding residues. Mutant (S315T) showed high doc... | PMID: 20593210

Large_pdficon_selected PDF is available here.
Molecular Cancer Therapeutics (10)4 2011
Context dependence of checkpoint kinase 1 as a therapeutic target for pancreatic cancers deficient in the BRCA2 tumor suppressor.
Hiroyoshi Hattori, Ferdinandos Skoulidis, Paul Russell and Ashok R Venkitaraman
Abstract
We have established an RNA interference (RNAi) screen to identify genes whose depletion selectively inhibits the growth of cells lacking BRCA2, and then studied the effects of the genetic depletion or pharmacologic inhibition of 1 candidate, the checkpoint kinase 1 (CHK1), in the context of pancreat... | PMID: 21289082

Large_pdficon_selected PDF is available here.
Journal of Molecular Modeling (17)4 2011
Studying the mechanism that enables paullones to selectively inhibit glycogen synthase kinase 3 rather than cyclin-dependent kinase 5 by molecular dynamics simulations and free-energy calculations.
Quan Chen, Wei Cui, Yuanhua Cheng, Fushi Zhang and Mingjuan Ji
Abstract
We investigated the mechanism that enables paullones to selectively inhibit GSK-3 rather than cyclin-dependent kinase 5 (CDK5) using sequence alignment, molecular dynamics simulations, free-energy calculations and free-energy decomposition analysis. The results indicate that the interaction between... | PMID: 20559856

Large_pdficon_selected PDF is available here.
Journal of Molecular Modeling (17)4 2011
Studying the mechanism that enables paullones to selectively inhibit glycogen synthase kinase 3 rather than cyclin-dependent kinase 5 by molecular dynamics simulations and free-energy calculations.
Quan Chen, Wei Cui, Yuanhua Cheng, Fushi Zhang and Mingjuan Ji
Abstract
We investigated the mechanism that enables paullones to selectively inhibit GSK-3 rather than cyclin-dependent kinase 5 (CDK5) using sequence alignment, molecular dynamics simulations, free-energy calculations and free-energy decomposition analysis. The results indicate that the interaction between... | PMID: 20559856

Large_pdficon_selected PDF is available here.
Molecular Therapy (19)3 2011
Mechanistically probing lipid-siRNA nanoparticle-associated toxicities identifies Jak inhibitors effective in mitigating multifaceted toxic responses.
Weikang Tao, Xianzhi Mao, Joseph P Davide, Bruce Ng, Mingmei Cai, Paul A Burke, Alan B Sachs and Laura Sepp-Lorenzino
Abstract
A major hurdle for harnessing small interfering RNA (siRNA) for therapeutic application is an effective and safe delivery of siRNA to target tissues and cells via systemic administration. While lipid nanoparticles (LNPs) composed of a cationic lipid, poly-(ethylene glycol) lipid and... | PMID: 21179008

Large_pdficon_selected PDF is available here.
Nature Reviews: Rheumatology (7)3 2011
Therapy: Spleen tyrosine kinase inhibitors--novel therapies for RA?
José A Gómez-Puerta and Xavier Bosch
Abstract
In patients with active rheumatoid arthritis despite therapy with DMARDS, treatment with a spleen tyrosine kinase inhibitor has achieved similar response rates to those achieved in clinical trials of other drugs, including biologic agents. Where might these agents fit in the current... | PMID: 21304505

Large_pdficon_selected PDF is available here.
Current Cancer Drug Targets (11)3 2011
SCF E3 ubiquitin ligases as anticancer targets.
L Jia and Y Sun
Abstract
We review recent advances in validation of SCF E3 ubiquitin ligase complex as an attractive anti-cancer target and discuss how MLN4924, a small molecule inhibitor of NEDD8-activating enzyme, can be developed as a novel class of anticancer agents by inhibiting SCF E3 ligase complex via removal of cul... | PMID: 21247385

Large_pdficon_selected PDF is available here.
European Journal of Gastroenterology and Hepatology (23)3 2011
Serum hepcidin and prohepcidin concentrations in inflammatory bowel disease.
Pantelis Oustamanolakis, Ioannis E Koutroubakis, Ippokratis Messaritakis, Niki Malliaraki, Aekaterini Sfiridaki and Elias A Kouroumalis
Abstract
Anemia is an important complication of inflammatory bowel disease (IBD). Recent data suggest that hepcidin is a major mediator of anemia with a central role in iron homeostasis and metabolism. The aim of this study was to evaluate the serum levels of hepcidin and its prohormone, proh... | PMID: 21285884

Large_pdficon_selected PDF is available here.
Cancer Cell (19)2 2011
Tumor-derived JAGGED1 promotes osteolytic bone metastasis of breast cancer by engaging notch signaling in bone cells.
Nilay Sethi, Xudong Dai, Christopher G Winter and Yibin Kang
Abstract
We report that the Notch ligand Jagged1 is a clinically and functionally important mediator of bone metastasis by activating the Notch pathway in bone cells. Jagged1 promotes tumor growth by stimulating IL-6 release from osteoblasts and directly activates osteoclast differentiation. Furthermore, Jag... | PMID: 21295524

Large_pdficon_selected PDF is available here.
Cancer Cell (19)2 2011
Tumor-derived JAGGED1 promotes osteolytic bone metastasis of breast cancer by engaging notch signaling in bone cells.
Nilay Sethi, Xudong Dai, Christopher G Winter and Yibin Kang
Abstract
We report that the Notch ligand Jagged1 is a clinically and functionally important mediator of bone metastasis by activating the Notch pathway in bone cells. Jagged1 promotes tumor growth by stimulating IL-6 release from osteoblasts and directly activates osteoclast differentiation. Furthermore, Jag... | PMID: 21295524

Large_pdficon_selected PDF is available here.
Journal of Proteomics (74)2 2011
2-DE-based proteomic analysis of common bean (Phaseolus vulgaris L.) seeds.
M De La Fuente, A Borrajo, J Bermúdez, M Lores, J Alonso, M López, M Santalla, A M De Ron, C Zapata and G Alvarez
Abstract
We report here a proteomic analysis of bean seeds by two-dimensional electrophoresis (2-DE). Three different protein extraction methods (TCA-acetone, phenol and the commercial clean-up kit) were used taking into account that the extractome can have a determinant impact on the level of quality of dow... | PMID: 20971221

Large_pdficon_selected PDF is available here.
Journal of Physiology (589)Pt 3 2011
Oxygen's double-edged sword: balancing muscle O2 supply and use during exercise.
David C Poole
Abstract
PMID: 21285027

Large_pdficon_selected PDF is available here.
Arthritis & Rheumatism (63)2 2011
An oral Syk kinase inhibitor in the treatment of rheumatoid arthritis: a three-month randomized, placebo-controlled, phase II study in patients with active rheumatoid arthritis that did not respond to biologic agents.
Mark C Genovese, Arthur Kavanaugh, Michael E Weinblatt, Charles Peterfy, Julie DiCarlo, Michael L White, Maryann O'Brien, Elliott B Grossbard and Daniel B Magilavy
Abstract
Our findings indicate that there were no differences in the primary end point between the R788 and placebo groups. Differences were observed between the R788 and placebo groups in secondary end points, particularly in those patients who entered the study with an elevated CRP level. C... | PMID: 21279990

Large_pdficon_selected PDF is available here.
Medical Letter on Drugs & Therapeutics (Abstracts) (53)1355 2011
Antiviral drugs for influenza.
Author(s) unavailable
Abstract
PMID: 21212742

Large_pdficon_selected PDF is available here.
Frontiers in bioscience (elite edition) (3) 2011
Acylated catechin derivatives: inhibitors of DNA polymerase and angiogenesis.
Yoshiyuki Mizushina, Akiko Saito, Keiko Horikawa, Noriyuki Nakajima, Akira Tanaka, Hiromi Yoshida and Kiminori Matsubara
Abstract
We previously found that some catechins, such as epigallocatechin-3-O-gallate (EGCG), inhibit the activities of eukaryotic DNA polymerases (pols) (Y. Mizushina et al.: Structural analysis of catechin derivatives as mammalian DNA polymerase inhibitors. Biochem Biophys Res Commun 333, 101-109 (2005)).... | PMID: 21622140

Large_pdficon_selected PDF is available here.
Science Signaling (4)174 2011
Progress in the function and regulation of ADP-Ribosylation.
Michael O Hottiger, Mark Boothby, Friedrich Koch-Nolte, Bernhard Lüscher, Niall M B Martin, Ruth Plummer, Zhao-Qi Wang and Mathias Ziegler
Abstract
Adenosine 5'-diphosphate (ADP)-ribosylation is a protein posttranslational modification that is catalyzed by ADP-ribosyltransferases (ARTs), using nicotinamide adenine dinucleotide (NAD(+)) as a substrate. Mono-ribosylation can be extended into polymers of ADP-ribose (PAR). Poly(ADP-... | PMID: 21610250

Large_pdficon_selected PDF is available here.
Pharmacological reports : PR (63)3 2011
Therapeutic potential of adenosine analogues and conjugates.
Monika Samsel and Krystyna Dzierzbicka
Abstract
This review summarizes current knowledge of adenosine analogues and conjugates with promising therapeutic properties. Adenosine is a signaling molecule that triggers numerous physiological responses. It acts through the adenosine receptors (ARs), belonging to the family of G-protein-... | PMID: 21857072

Large_pdficon_selected PDF is available here.
Journal of Toxicology and Environmental Health, Part A: Current Issues (74)1 2011
Quantitative structure-activity relationships for organophosphates binding to trypsin and chymotrypsin.
Christopher D Ruark, C Eric Hack, Peter J Robinson and Jeffery M Gearhart
Abstract
Organophosphate (OP) nerve agents such as sarin, soman, tabun, and O-ethyl S-[2-(diisopropylamino) ethyl] methylphosphonothioate (VX) do not react solely with acetylcholinesterase (AChE). Evidence suggests that cholinergic-independent pathways over a wide range are also targeted, inc... | PMID: 21120745

Large_pdficon_selected PDF is available here.
Journal of Hematology & Oncology (4)1 2011
Novel targeted therapeutics: inhibitors of MDM2, ALK and PARP
Yuan Yuan, Yu-Min Liao, Chung-Tsen Hsueh and Hamid R Mirshahidi
Abstract
We reviewed preclinical data and clinical development of MDM2 (murine double minute 2), ALK (anaplastic lymphoma kinase) and PARP (poly [ADP-ribose] polymerase) inhibitors. MDM2 binds to p53, and promotes degradation of p53 through ubiquitin-proteasome degradation. JNJ-26854165 and RO5045337 are 2 s... | PMID: 21504625

Large_pdficon_selected PDF is available here.
Vascular Pharmacology (54)3-6 2011
Tyrphostin AG490 reduces NAPDH oxidase activity and expression in the aorta of hypercholesterolemic apolipoprotein E-deficient mice.
Ioana M Fenyo, Irina C Florea, Monica Raicu and Adrian Manea
Abstract
We investigated the potential of Jak2 inhibition to counteract Nox-dependent O(2)(•-) formation in atherogenesis in hypercholesterolemic apolipoprotein E-deficient (ApoE(-/-)) mice. Male ApoE(-/-) mice fed a high-fat, cholesterol-rich diet were treated for 5 weeks with either vehicle or tyrphostin... | PMID: 21457788

Large_pdficon_selected PDF is available here.
Frontiers in bioscience (elite edition) (3) 2011
Antitumor activity of NPB001-05, an orally active inhibitor of Bcr-Abl tyrosine kinase.
Vilas Wagh, Prabha Mishra, Arvind Thakkar, Vaibhav Shinde, Somesh Sharma, Muralidhara Padigaru and Kalpana Joshi
Abstract
We tested gene expression of PI3K, AKT1, JUN, CASP3 and DDIT3 in K562, BaF3P210(BCR-ABL) and BaF3 P210(BCR-ABLT315I) cell line treated for 6- and 12- hours with NPB001-05 and imatinib. The data indicates that NPB001-05 mediated cell death in K562 affects the function of ER stress. NPB001-05 shows an... | PMID: 21622141

Large_pdficon_selected PDF is available here.
PLoS ONE (6)7 2011
Novel PI3K/Akt inhibitors screened by the cytoprotective function of human immunodeficiency virus type 1 Tat.
Yuri Kim, Joseph A Hollenbaugh, Dong-Hyun Kim and Baek Kim
Abstract
We exploited the PI3K/Akt dependent cytoprotective effect of Tat-expressing CHME5 cells. We screened a collection of compounds known to modulate inflammation, and identified three novel compounds: Lancemaside A, Compound K and Arctigenin that abolished the cytoprotective phenotype of Tat-expressing... | PMID: 21765914

Large_pdficon_selected PDF is available here.
Neonatology (99)2 2011
Lipopolysaccharide-induced expression of Th1/Th2 cytokines in whole neonatal cord and adult blood: role of nuclear factor-kappa B and p38 MAPK.
Lutz Koch, Benedikt Fritzsching, David Frommhold and Johannes Poeschl
Abstract
We studied the effects of lipopolysaccharide (LPS) on expression and function of NF-κB and p38 MAPK in whole neonatal cord and adult blood. Th1/Th2 cytokine concentrations and phosphorylation of NF-κB and p38 MAPK were determined by flow-cytometric analysis. Tumor n... | PMID: 20798552

Large_pdficon_selected PDF is available here.
Journal of Vascular Research (48)1 2011
Pro-inflammatory effects of interleukin-17A on vascular smooth muscle cells involve NAD(P)H- oxidase derived reactive oxygen species.
Eweline Pietrowski, Bianca Bender, Jula Huppert, Robin White, Heiko J Luhmann and Christoph R W Kuhlmann
Abstract
T cells are known for their contribution to the inflammatory element of atherosclerosis. Recently, it has been demonstrated that the Th17 derived cytokine IL-17 is involved in the pro-inflammatory response of vascular smooth muscle cells (VSMC). The aim of the present study was to examine whether re... | PMID: 20606471

Large_pdficon_selected PDF is available here.
Methods in Molecular Biology (685) 2011
Structure-based library design in efficient discovery of novel inhibitors.
Shunqi Yan and Robert Selliah
Abstract
Structure-based library design employs both structure-based drug design (SBDD) and combinatorial library design. Combinatorial library design concepts have evolved over the past decade, and this chapter covers several novel aspects of structure-based library design together with successful case stud... | PMID: 20981524

Large_pdficon_selected PDF is available here.
Journal of Vascular Research (48)1 2011
Oxygen-dependent vasomotor responses are conducted upstream in the mouse cremaster microcirculation.
Mads Riemann, Amrit Rai, Anh Thuc Ngo, Morten Hanefeld Dziegiel, Niels-Henrik Holstein-Rathlou and Christian Torp-Pedersen
Abstract
We tested whether hypoxic vasodilation and hyperoxic vasoconstriction in arterioles in striated muscle are being propagated upstream, and whether the endothelium and smooth muscle cell layers are necessary components in the signaling pathway. The study was performed in mouse cremaster muscle superfu... | PMID: 20639650

Large_pdficon_selected PDF is available here.
Methods in Molecular Biology (685) 2011
Structure-based and property-compliant library design of 11β-HSD1 adamantyl amide inhibitors.
Genevieve D Paderes, Klaus Dress, Buwen Huang, Jeff Elleraas, Paul A Rejto and Tom Pauly
Abstract
Multiproperty lead optimization that satisfies multiple biological endpoints remains a challenge in the pursuit of viable drug candidates. Optimization of a given lead compound to one having a desired set of molecular attributes often involves a lengthy iterative process that utilizes existing infor... | PMID: 20981525

Large_pdficon_selected PDF is available here.
Methods in Molecular Biology (692) 2011
High-performance liquid chromatography analysis of N-acyl homoserine lactone hydrolysis by paraoxonases.
John F Teiber and Dragomir I Draganov
Abstract
Mammalian paraoxonases (PONs) are a unique, highly conserved family of calcium-dependent esterases consisting of PON1, PON2, and PON3. The PONs can hydrolyze the lactone ring of a range of N-acyl-L: -homoserine lactone (AHL) quorum sensing signaling molecules, rendering them inactive. This chapter d... | PMID: 21031320

Large_pdficon_selected PDF is available here.
Biochimica et Biophysica Acta (1811)1 2011
Mouse serum paraoxonase-1 lactonase activity is specific for medium-chain length fatty acid lactones.
Philip W Connelly, Clive M Picardo, Philip M Potter, John F Teiber, Graham F Maguire and Dominic S Ng
Abstract
We observed lactonase activity in serum from Pon1-/- mice. However, 6-12 carbon fatty acid γ- and δ-lactones were not hydrolyzed in serum from Pon1-/- mice. Serum from both wild-type and Pon1-/- mice contained a lactonase activity towards 5-HETEL and 3-oxo-dodecanoyl-homoserine lactone that was re... | PMID: 21044894

Large_pdficon_selected PDF is available here.
Toxicology and Applied Pharmacology (250)1 2011
Reactive oxygen species and oxidative DNA damage mediate the cytotoxicity of tungsten-nickel-cobalt alloys in vitro.
R M Harris, T D Williams, N J Hodges and R H Waring
Abstract
We have developed a rapid visual in vitro assay to detect toxicity mediated by individual WA particles in cultured L6-C11 rat muscle cells. Using a variety of techniques (histology, comet assay, caspase-3 activity, oxidation of 2'7'-dichlorofluorescin to measure the production of reactive oxygen spe... | PMID: 20934443

Large_pdficon_selected PDF is available here.